Yield10 Bioscience (YTEN) Getting Somewhat Positive Press Coverage, Study Finds

News articles about Yield10 Bioscience (NASDAQ:YTEN) have trended somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies positive and negative news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Yield10 Bioscience earned a coverage optimism score of 0.11 on Accern’s scale. Accern also gave news headlines about the specialty chemicals company an impact score of 45.8856010100526 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

These are some of the headlines that may have impacted Accern Sentiment’s scoring:

Shares of Yield10 Bioscience (YTEN) traded down $0.03 during trading on Wednesday, hitting $2.08. 43,600 shares of the stock traded hands, compared to its average volume of 15,693. Yield10 Bioscience has a 1-year low of $1.99 and a 1-year high of $9.30. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.76 and a current ratio of 1.76.

Yield10 Bioscience (NASDAQ:YTEN) last issued its quarterly earnings results on Thursday, November 9th. The specialty chemicals company reported ($0.59) earnings per share for the quarter. The business had revenue of $0.22 million for the quarter. Yield10 Bioscience had a negative return on equity of 214.42% and a negative net margin of 743.10%.

TRADEMARK VIOLATION WARNING: “Yield10 Bioscience (YTEN) Getting Somewhat Positive Press Coverage, Study Finds” was originally posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this story on another domain, it was illegally copied and republished in violation of international copyright and trademark laws. The legal version of this story can be viewed at https://ledgergazette.com/2017/12/06/yield10-bioscience-yten-getting-somewhat-positive-press-coverage-study-finds.html.

Yield10 Bioscience Company Profile

Yield10 Bioscience, Inc, formerly Metabolix, Inc, is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, the Company is advancing several yield traits it has developed in crops, such as Camelina, canola, soybean and corn.

Insider Buying and Selling by Quarter for Yield10 Bioscience (NASDAQ:YTEN)

Receive News & Ratings for Yield10 Bioscience Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply